Market Overview

(:) Press Releases

Wednesday, January 13, 2021

Marker Therapeutics Announces Completion of New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy Product Candidates (MRKR, Press Releases / Wed, 07:00am)

Tuesday, January 05, 2021

Thinking about buying stock in Zomedica, Zosano Pharma, TapImmune, Five Prime Therapeutics, or Inuvo? (FPRX, INUV, MRKR, ZOM, ZSAN, Opinion, Press Releases / Tue, 09:31am)
Marker Therapeutics Announces FDA Lifted Partial Clinical Hold on Phase 2 AML Clinical Trial (MRKR, Press Releases / Tue, 07:00am)

Monday, November 09, 2020

Marker Therapeutics Reports Third Quarter 2020 Operating and Financial Results (Earnings, MRKR, Press Releases / Mon, 04:01pm)
Marker Therapeutics, Inc. to Host Earnings Call (Earnings, MRKR, News, Press Releases / Mon, 03:15pm)

Monday, November 02, 2020

Marker Therapeutics to Host Third Quarter 2020 Operating and Financial Results Conference Call and Webcast on Monday, November 9, 2020 (MRKR, Press Releases / Mon, 07:00am)

Thursday, September 17, 2020

Marker Therapeutics to Present at the Virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (MRKR, Press Releases / Thu, 06:00am)

Monday, August 10, 2020

Marker Therapeutics Reports Second Quarter 2020 Operating and Financial Results (Earnings, MRKR, Press Releases / Mon, 03:00pm)

Tuesday, June 30, 2020

Marker Therapeutics Announces New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy Product Candidates (MRKR, Press Releases / Tue, 06:00am)

Tuesday, June 23, 2020

Marker Therapeutics Receives USAN Approval for "zelenoleucel" as Nonproprietary Name for MT-401, Multi-Tumor-Associated Antigen Targeted T Cell Product for Acute Myeloid Leukemia (MRKR, Press Releases / Tue, 06:00am)

Friday, May 29, 2020

Marker Therapeutics Reports Interim Results of its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting (MRKR, Press Releases / Fri, 07:00am)

Wednesday, May 13, 2020

Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at ASCO 2020 Annual Meeting (MRKR, Press Releases / Wed, 04:01pm)

Monday, May 11, 2020

Marker Therapeutics Reports First Quarter 2020 Operating and Financial Results (Earnings, MRKR, Press Releases / Mon, 03:05pm)

Monday, May 04, 2020

Marker Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast on Monday, May 11, 2020 (MRKR, Press Releases / Mon, 03:05pm)

Wednesday, April 29, 2020

Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia (MRKR, Press Releases / Wed, 03:05pm)

Thursday, March 12, 2020

Marker Therapeutics Reports Full Year 2019 Operating and Financial Results (Earnings, MRKR, Press Releases / Thu, 03:01pm)

Monday, March 02, 2020

Marker Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 million (MRKR, Offerings, Press Releases / Mon, 07:00am)

Tuesday, February 18, 2020

Marker Therapeutics to Present at Two Upcoming Investor Conferences (MRKR, Press Releases / Tue, 07:00am)

Tuesday, February 11, 2020

Marker Therapeutics Announces Update to its Clinical Program in AML (MRKR, Press Releases / Tue, 07:00am)

Monday, November 25, 2019

Marker Therapeutics to Present at Two Upcoming Investor Conferences (MRKR, Press Releases / Mon, 07:00am)

Tuesday, November 12, 2019

Marker Therapeutics Reports Third Quarter 2019 Operating and Financial Results (Earnings, MRKR, Press Releases / Tue, 04:01pm)

Monday, November 11, 2019

Marker Therapeutics to Host Third Quarter 2019 Operating and Financial Results Conference Call and Webcast on Tuesday, November 12, 2019 (MRKR, Press Releases / Mon, 07:00am)

Thursday, August 15, 2019

Marker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs (MRKR, Press Releases / Thu, 03:01pm)

Thursday, August 08, 2019

Marker Therapeutics Reports Second Quarter 2019 Operating and Financial Results (Earnings, MRKR, Press Releases / Thu, 03:01pm)

Tuesday, August 06, 2019

Marker Therapeutics Appoints Steve Elms to its Board of Directors (MRKR, Press Releases / Tue, 03:05pm)

Saturday, July 20, 2019

Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR (MRKR, Press Releases / Sat, 10:00am)

Wednesday, July 17, 2019

Marker Therapeutics to Host Conference Call and Webcast to Review Interim Results from Phase 1/2 Clinical Trial with its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma (MRKR, Press Releases / Wed, 06:00am)

Thursday, June 20, 2019

Tuesday, May 21, 2019

Marker Therapeutics to Present at Two Upcoming Investor Conferences (MRKR, Press Releases / Tue, 06:00am)

Thursday, May 09, 2019

Marker Therapeutics Reports First Quarter 2019 Operating and Financial Results (Earnings, MRKR, Press Releases / Thu, 03:01pm)

Tuesday, May 07, 2019

Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference (MRKR, Press Releases / Tue, 03:10pm)

Thursday, March 28, 2019

Marker Therapeutics Provides Business and Clinical Update (MRKR, Small Cap, Press Releases / Thu, 03:05pm)

Monday, March 18, 2019

Marker Therapeutics to Host Business Update Conference Call and Webcast on Thursday, March 28th (MRKR, Small Cap, Press Releases / Mon, 06:00am)

Monday, February 25, 2019

Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019 (MRKR, Press Releases / Mon, 07:00am)

Thursday, February 21, 2019

Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award (MRKR, Press Releases / Thu, 06:00pm)

1	AAPL: Apple Tests Foldable Screen For iPhone: Bloomberg
2	CVX, AMZN: Barron's Picks And Pans: Exxon Mobil, GameStop, Intel, 3M, Tol...
3	SPCE, MP: Investors Want A Chamath Palihapitiya ETF And They Might Ge...
4	TSLA, XPEV: Tesla Takes Legal Action Against Chinese News Out...
5	DFH, MYTE: 4 Companies To Join Hot IPO Market This...
6	TSLA: Elon Musk Donates $5M To Online Educ...
7	YORW, GBIO: Notable Insider Buys Of Th...

1	How Globalization Has Affected The Dollar
2	What's Going To Drive Volatility In 2021?
3	Agriculture Update: The Soybean Market Is Hot
4	What Should We Expect From Small-Cap Stocks?
5	CGC, MMEDF: What Will The Psychedelics Space Look Like In 2021? Experts Weigh In
6	FTC's Crackdown Against CBD Market Stirs Mixed Feelings Among Can...
7	Valuable Real Estate Tax Benefit Should Escape The Chopping Block, But...